implementation of low-cost drugs confused directory- pharmaceutical marketing policy perspective(实现低成本药品混淆目录u2014u2014医药营销政策的角度).docVIP

implementation of low-cost drugs confused directory- pharmaceutical marketing policy perspective(实现低成本药品混淆目录u2014u2014医药营销政策的角度).doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
implementation of low-cost drugs confused directory- pharmaceutical marketing policy perspective(实现低成本药品混淆目录u2014u2014医药营销政策的角度)

Implementation of low-cost drugs confused directory: Pharmaceutical marketing policy perspective National drug catalog introduction of low-priced starting point is to protect low-priced products, especially generic drugs homogeneity strong product avoid hanging purchases due to intense competition, price margins drastically reduced until less than the operating costs of enterprises and channel marketing, companies have no incentive Even upside down management, case goods sadly disappearing from the market. But from a market point of view of the implementation of low-cost drugs, but inevitably confused directory. First, the average daily cost of cheap medicine directory medicine three yuan, Chinese 5 yuan, 21 yuan, compared with weeks of treatment costs and $ 35 monthly cost of treatment, compared with 90 and 150 respectively. Already close to or even higher than many new drugs, new formulations retail price, taking into account the price factor linked network, there will be some of the traditional price of generic drugs over a large area of #8203;#8203;high drug non-normal conditions after the actual implementation. With better outcomes, better treatment cost of survival of the fittest is the natural law of the market competition. Scale production of generic drugs should be significantly lower than the cost of the drug product, the marketing of generic drugs is much lower than the operating costs of new drug products. Ensure that the market is more in line with the objective of fair competition law is extremely important. Second, when the countries to develop low-cost directory does not fully take into account differences in the cost of production formulations and doses, the average daily use of a low-cost drugs and 10 injections, 1 and 18 tablets cost of production is completely different. Version GMP transformation after injection products cost much higher than oral products, the same will be the actual implementation of the oral tradition of generic drug

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档